Does biopsy accurately assess basal cell carcinoma (BCC) subtype?

J Am Acad Dermatol. 2016 Apr;74(4):758-60. doi: 10.1016/j.jaad.2015.10.025.

Authors

Roel E Genders¹, Marti C Kuizinga², Thea M Teune², Monique van der Kruijk³, Annik van Rengen⁴

Affiliations

¹ Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Dermatology, Roosevelt Kliniek, Leiden, The Netherlands. Electronic address: r.e.genders@lumc.nl.
² Laboratory for Pathology, Dordrecht, The Netherlands.
³ Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Mohs Klinieken, Dordrecht, The Netherlands.

PMID: 26979358
DOI: 10.1016/j.jaad.2015.10.025

No abstract available

Publication types

Evaluation Study
Letter

MeSH terms

Biopsy, Needle / methods*
Carcinoma, Basal Cell / classification
Carcinoma, Basal Cell / pathology*
Carcinoma, Basal Cell / surgery
Cohort Studies
Female
Humans
Male
Mohs Surgery / methods*
Neoplasm Invasiveness / pathology
Neoplasm Staging
Observer Variation
Prospective Studies
Sensitivity and Specificity
Skin Neoplasms / classification
Skin Neoplasms / pathology*
Skin Neoplasms / surgery